MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced Parkinson’s Disease: Study Design and Status Update

T. Simuni, B. Fiske, K. Merchant, C. Coffey, H. Matthews, R. Wyse, P. Brundin, D. Simon, M. Schwarzschild, D. Weiner, J. Adams, C. Venuto, L. Trusso, L. Baker, M. Kostrzebski, T. Ward, G. Rafaloff (Boston, MA, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3
1:45pm-3:15pm
NKX2-1-Related Disorder with Cerebral Folate Deficiency

J. Maclean, Q. Luc, L. Ramos-Platt, S. Saitta, C. Quindipan (Los Angeles, CA, USA)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Non-CpG methylation in the FXN gene in patients with Friedreich’s ataxia

E. Nuzhnyi, N. Abramycheva, M. Ershova, S. Klyushnikov, N. Nikolaeva, S. Illarioshkin, E. Fedotova (Moscow, Russian Federation)

Ataxia  ·  Les Muses, Level 3
1:45pm-3:15pm
Non-Medical Switching: Impact on Movement Disorders Patients’ Access and Care

B. Kennedy, J. Peterson, D. Charles (Washington, DC, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Normative Curves for Selected Unified Huntington Disease Rating Scale Measures

J. Mills, J. Long, A. Mohan, J. Ware, C. Sampaio (Iowa City, IA, USA)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Normative Reference for Timed Up and Go Test (TUG) in Young Indian Adults- Preliminary Results

D. Kaur, K. Umakant, T. Aziz, P. Jaiswal, M. Kumari, A. Gupta, G. Kumar (Patna, India)

Ataxia  ·  Les Muses, Level 3
1:45pm-3:15pm
Novel exploratory outcome assessments in GENERATION HD1

D. Trundell, S. Schobel, R. Roos, K. Anderson, A. Thobhani, G. Hooper, M. Nguyen, S. Tabrizi (Welwyn Garden City, United Kingdom)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Novel Mutation of NUS1 Gene Presenting With Developmental And Epileptic Encephalopathy and Movement Disorders

N. Prakash, N. Mencacci, C. Zadikoff, L. Kinsley, T. Simuni, S. Lubbe, D. Krainc (Chicago, IL, USA)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Novel p.Pro193Arg missense mutation in ABCD1-gene associated with phenotype of ALD/AMN: a case report

K. Steidel, J. Waldthaler, C. Eggers, D. Pedrosa (Marburg, Germany)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Objective quantifiable assessment of nocturnal movements in patients with Parkinson’s disease using a wearable sensor

A. Mirelman, I. Hillel, L. Rochester, A. Nieuwboer, B. Bloem, L. Avanzino, S. Shema-Shiratzki, I. Maidan, T. Herman, J. Cederbaum, N. Giladi, J. Hausdorff (Tel Aviv, Israel)

Other  ·  Agora 2 West, Level 2
  • «Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley